(Q36538437)

14 August 2017

Hepatotoxicity caused by the combined action of isoniazid and rifampicin (English)

1 reference

14 August 2017

1 reference

0 references

D S Askgaard

1

1 reference

14 August 2017

T Wilcke

series ordinal

2

1 reference

14 August 2017

M Døssing

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

14 August 2017

1 reference

14 August 2017

50

1 reference

14 August 2017

2

1 reference

14 August 2017

213-214

1 reference

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

14 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473930

30 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=473930

Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy

30 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7701468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7701468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Drug-induced liver disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7701468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.50.2.213

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

7701468

1 reference